Arakis collaborates with GeneFormatics for joint discovery of Performance Enhanced Medicines (PEMs) by combining GeneFormatics’ structural proteomics capabilities to identify and describe secondary biochemical functional sites and Arakis’ know-how and databases to define and validate protein targets.